https://www.psychiatrictimes.com/view/hopeful-horizons-the-potential-of-rapid-acting-therapies-in-mdd
Clinicians discuss the particular benefits of rapid-acting agents for major depressive disorder (MDD), highlighting the gap glutamate-modulating agents fill in targeted therapies.
Create an account or login to join the discussion